<DOC>
	<DOCNO>NCT00058058</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure magnetic resonance imaging ( MRI ) may improve ability detect cancer unaffected breast woman recently diagnose unilateral breast cancer . PURPOSE : Diagnostic trial determine effectiveness MRI evaluating unaffected breast woman recently diagnose unilateral breast cancer .</brief_summary>
	<brief_title>Magnetic Resonance Imaging Women Recently Diagnosed With Unilateral Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine diagnostic yield magnetic resonance imaging ( MRI ) evaluate contralateral breast woman recent unilateral diagnosis breast cancer negative contralateral mammogram clinical breast exam . - Determine sensitivity , specificity , positive predictive value call back additional imaging biopsy recommendation , receiver operate characteristic curve MRI evaluate patient . - Determine effect follow patient-related factor : age ( 50 year old v le 50 year old ) , breast parenchymal density ( fatty v non fatty breast ) , tumor histology ( invasive lobular v invasive ductal , invasive v situ ) performance MRI ( cancer yield , sensitivity , specificity , PPV ) . OUTLINE : This multicenter study . Patients receive gadopentetate dimeglumine IV undergo magnetic resonance image contralateral breast . Patients follow 12-18 24-30 month . PROJECTED ACCRUAL : A total 1,000 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Recently confirm unilateral ductal carcinoma situ invasive cancer breast Confirmed biopsy fine needle aspiration ( FNA ) within past 60 day Negative benign mammogram ( BIRADS assessment 1 2 ) negative benign clinical breast exam contralateral breast within past 90 day Prior biopsy contralateral breast ( include FNA ) allow provide perform least 6 month prior study entry Prior magnetic resonance exam contralateral breast allow provide perform least 1 year prior study entry No remote history breast cancer No new breast symptom within past 60 day evaluation recommend Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age 18 Sex Female Menopausal status Not specify Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Cardiovascular No pacemaker No magnetic aneurysm clip Other Not pregnant No implant magnetic device No severe claustrophobia No contraindication MRI No psychiatric , psychological , condition would preclude informed consent PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy At least 6 month since prior anticancer chemotherapy Endocrine therapy No concurrent therapeutic hormonal therapy , tamoxifen , aromatase inhibitor ( preventive therapy allow ) Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2004</verification_date>
	<keyword>ductal breast carcinoma situ</keyword>
	<keyword>invasive ductal breast carcinoma</keyword>
	<keyword>invasive lobular breast carcinoma</keyword>
	<keyword>breast cancer situ</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
</DOC>